ACTRN12612000347864尚未招募不适用
Randomised placebo controlled cross-over trial of airway humidification, in patients withpSS(Primary Sjogrens Syndrome) and to study its effect on sleep architecture.
Adelaide Institute for Sleep health0 个研究点目标入组 20 人开始时间: 2012年3月26日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •Patients with primary Sjogrens Syndrome (pSS), as per the revised version of the European criteria proposed by the American-European Consensus Group, with an Apnea-hypopnea index (AHI) of >10 events/hour, measured on polysomnogram.
排除标准
- •Inability to give consent, co-existing sleep disorders like restless leg syndrome,narcolepsy etc, major medical co-morbidities like unstable heart disease, unstable airways disease,uncontrolled diabetes mellitus, patients on chemotherapy
研究者
相似试验
已完成
不适用
Randomised placebo controlled cross-over trial of topical opioids in the management of analgesia in leg ulcersSigns and Symptoms: PainSkin and Connective Tissue DiseasesOther disorders of skin and subcutaneous tissue, not elsewhere classifiedISRCTN76288165Department of Health (UK)20
已完成
1 期
A randomised placebo controlled crossover trial to evaluate the effects of intrajejunal taurocholic acid on gastrointestinal hormone secretion and glycaemia in response to intrajejunal glucose infusion in healthy humans for the future design of treatments for type 2 diabetes mellitusACTRN12612001213831Royal Adelaide Hospital14
已完成
1 期
A randomised placebo controlled crossover trial to evaluate the effects of different doses of taurocholic acid in a suppository on gastrointestinal hormone secretion and appetite in healthy humans.Type 2 diabetes mellitusMetabolic and Endocrine - DiabetesDiet and Nutrition - ObesityObesityACTRN12610000520033Royal Adelaide Hospital12
已完成
不适用
Protease supplementation and delayed onset muscle soreness (DOMS)ACTRN12612000467831niversity of Otago30
已完成
2 期
Effects of Hydroxycitrate (HCA) on intestinal glucose absorption and incretin releaseType 2 diabetes mellitusMetabolic and Endocrine - DiabetesACTRN12615000088549niversity of Adelaide20